Summary
Latest filing:
Noubar Afeyan files SEC Form 4 reports at Moderna, Inc. (MRNA). 4 SEC Form 4 filings on record going back to 2025, most recently on 22 May 2026. Most recent open-market trade: sold $434K of MRNA on 22 May 2026. Lifetime open-market purchases: $75.00M. Lifetime open-market sales: $434K. Historical track record: 5/5 stars across 3 tracked purchases.
Recent Transactions
10Every recent SEC Form 4 transaction Noubar Afeyan has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +0.00% |
| Avg 30-day return | +9.37% |
| Avg 90-day return | +6.57% |
| Best 30-day return | +9.37% |
Trading Pattern
InsiderAlpha's records for Noubar Afeyan go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $25.00M (3 buys totaling $75.00M). The largest single buy on record is $25.00M of GENB in 2026. Sales side: 1 recorded sale totaling $434K, so the filing history runs buy-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Noubar Afeyan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephane Bancel - $28.72M of MRNA open-market activity in the last 12 months
- Stephen Hoge - $28.43M of MRNA open-market activity in the last 12 months
- James M. Mock - $4.69M of MRNA open-market activity in the last 12 months
- Shannon Thyme Klinger - $1.39M of MRNA open-market activity in the last 12 months
- Abbas Hussain - $265K of MRNA open-market activity in the last 12 months
- Michael Nally - $240K of GENB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Noubar Afeyan?
Noubar Afeyan is a corporate insider of Moderna, Inc. (MRNA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Noubar Afeyan last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 4 filings going back to 2025.
Has Noubar Afeyan been buying or selling stock?
Recorded transactions: 3 open-market purchases ($75.00M) and 1 open-market sale ($434K) across all tracked filings.
How accurate is Noubar Afeyan's historical track record?
Across 3 tracked purchases, Noubar Afeyan averaged +9.4% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Noubar Afeyan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Noubar Afeyan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial